Compare ELAN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | RGC |
|---|---|---|
| Founded | 1954 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.5B |
| IPO Year | 2018 | 2020 |
| Metric | ELAN | RGC |
|---|---|---|
| Price | $23.44 | $29.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $27.89 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 85.7K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $4,715,000,000.00 | N/A |
| Revenue This Year | $8.21 | N/A |
| Revenue Next Year | $5.31 | N/A |
| P/E Ratio | $218.23 | ★ N/A |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $12.30 | $9.39 |
| 52 Week High | $27.72 | $950.00 |
| Indicator | ELAN | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 49.69 | 52.72 |
| Support Level | $22.04 | $21.81 |
| Resistance Level | $24.06 | $36.75 |
| Average True Range (ATR) | 1.12 | 2.17 |
| MACD | 0.22 | 0.00 |
| Stochastic Oscillator | 34.69 | 54.01 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.